S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
ASX:EMV

EMVision Medical Devices (EMV) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
192,157 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EMV stock logo

About EMVision Medical Devices Stock (ASX:EMV)

EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

EMV Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
EMvision Medical Devices Ltd.
Best Affordable Medical Alert Systems
Halma Buys Rovers Medical Devices for $92.1 Mln
EMVision Sets Sight on US With US$10M Keysight Investment
West Coast Device Alliance Announces Formation at IME West 2024
Boston Medical Devices News
See More Headlines
Receive EMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2019
Today
4/19/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,220,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.68 million
Book Value
A$0.07 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.58
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Scott Kirkland
    CEO, MD & Executive Director
  • Ms. Emma Waldon (Age 48)
    CFO & Company Secretary
  • Ms. Forough Khandan
    Chief Technology Officer
  • Prof. Stuart Crozier B.E.
    M.Sc., Ph.D., Chairman of Clinical Advisory Board & Chief Scientific Officer
  • Mr. Robert Tiller
    Head of Design
  • Dr. Konstanty Bialkowski
    Head of Tech Development
  • Dr. Christian Wight
    Head of Regulatory Affairs

EMV Stock Analysis - Frequently Asked Questions

How were EMVision Medical Devices' earnings last quarter?

EMVision Medical Devices Ltd (ASX:EMV) posted its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) earnings per share (EPS) for the quarter. EMVision Medical Devices had a negative net margin of 37.17% and a negative trailing twelve-month return on equity of 47.66%.

This page (ASX:EMV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners